In pancreatic ductal carcinoma, Shimizu et al. [21] reported that CA125 and mesothelin bind and that the blockage of CA125 binding to mesothelin by an antibody inhibited both invasion and migration of a pancreatic cancer cell line in vitro. Here, MUC16 is linked to pancreatic neoplasm.